Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.05.2023 | Case report

Antineoplastics

Chronic lymphocytic leukemia, lack of efficacy and off label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Burgess M, et al. Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia. Acta Haematologica 146: 166-171, No. 2, Jan 2023. Available from: URL: http://doi.org/10.1159/000527631 Burgess M, et al. Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia. Acta Haematologica 146: 166-171, No. 2, Jan 2023. Available from: URL: http://​doi.​org/​10.​1159/​000527631
Metadaten
Titel
Antineoplastics
Chronic lymphocytic leukemia, lack of efficacy and off label use: case report
Publikationsdatum
01.05.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38285-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Nivolumab

Case report

Multiple drugs